PLUS THERAPEUTICS, INC. — Director's Dealing 2023

Feb 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2023-02-15

Reporting Person: Sims Andrew John Hugh MacIntyre (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-15	Stock Option (Right to Buy)	$0.39	A	104404	Acquired	2033-02-15	Common Stock (104404)	Direct

Footnotes

F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.